HealthEquity Inc HQY 深 沪
等待开盘 05-12 09:30:00 美东时间
82.68
-2.145
-2.53%
华盛通- 最 高84.99
- 今 开84.46
- 成交量 32.45万股
- 最 低 81.68
- 昨 收 84.825
- 总市值 697.55万
- 52周最高 116.65
- 市盈率 静 --
- 换手率 384.62%
- 52周最低 72.76
- 委 比 -46.94%
- 总股本 8.44万
- 历史最高 116.65
- 量 比 0.68
- 振 幅 3.90%
- 历史最低 1.10
- 每 手 1
- 风险率 8.50%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HealthEquity Affirms FY2027 Sales Guidance of $1.380B-$1.410B
HealthEquity (NASDAQ:HQY) affirms FY2027 sales outlook from $1.380 billion-$1.410 billion to $1.380 billion-$1.410 billion.
02-18 06:40
HealthEquity Reaffirms Fiscal 2026 Outlook, Expects Fiscal 2027 Revenue Of ~$1.41B
HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the "Company"), the nation's largest health savings account ("HSA") custodian by number of accounts and leading provider of complimentary consumer-directed benefits
01-12 21:55
HealthEquity上调2026财年业绩指引
美股周三早盘，美国最大的健康储蓄账户非银行托管机构之一HealthEquity（HQY）股价上涨4.3%，此前该公司在人工智能服务进步和健康储蓄账户市场扩张的推动下，上调了2026财年业绩指引。 该公司预计健康储蓄账户现金收益率将达到3.5%。 海量资讯、精准解读，尽在新浪财经APP 责任编辑：张俊 SF065
2025-09-03 22:53
HCIT板块强劲，高盛唱多：Teladoc等股仍有望上行
医疗信息技术(HCIT)股票年初至今表现强劲，高盛发布美国医疗保健领域中HCIT和数字健康行业的研究报告，称行业运营环境正趋向正常化，未来仍有催化剂带动上行，并维持对该板块个股Teladoc Health(TDOC.US)的买入评级。 HCIT股票年初至今表现突出，多只股票涨幅显著超越罗素2000指数。如Teladoc Health上涨57.6%、Doximity(DOCS.US)上涨44.4%、Health Equity(HQY.US)上涨17.4%，同期罗素2000指数仅上涨2.2%。新冠疫情后，虚拟护理模式的预期下调，估值倍数相应调整，此前HCIT股票价格多年来表现不一，此次则出现反弹。...
2025-02-19 17:04
Navigating 8 Analyst Ratings For HealthEquity
Ratings for HealthEquity (NASDAQ:HQY) were provided by 8 analysts in the past t...
2024-09-21 00:00
Barrington Research Maintains Outperform on HealthEquity, Maintains $105 Price Target
Barrington Research analyst Alexander Paris maintains HealthEquity (NASDAQ:HQY) with a Outperform and maintains $105 price target.
2024-09-05 08:28
Deutsche Bank Maintains Buy on HealthEquity, Raises Price Target to $103
Deutsche Bank analyst George Hill maintains HealthEquity (NASDAQ:HQY) with a Buy and raises the price target from $102 to $103.
2024-09-05 01:23
B of A Securities Maintains Buy on HealthEquity, Lowers Price Target to $100
B of A Securities analyst Allen Lutz maintains HealthEquity (NASDAQ:HQY) with a Buy and lowers the price target from $105 to $100.
2024-09-04 20:06
HealthEquity Fiscal Q2 Non-GAAP Earnings, Revenue Rise; Fiscal 2025 Outlook Raised
04:14 PM EDT, 09/03/2024 (MT Newswires) -- HealthEquity (HQY) reported fiscal Q2 non-GAAP diluted earnings late Tuesday of $0.86 per share, up from $0.53 a year earlier. Analysts surveyed by Capital IQ expected $0.70. Revenue for the quarter ended July 31 was $299.9 million, up from $243.5 million a...
2024-09-04 04:14
